Filter
143
Text search:
drug
import
Featured
Recommendations
10
New Publications
39
Language
Document type
No document type
64
Studies & Reports
31
Guidelines
28
Manuals
11
Strategic & Response Plan
5
Resource Platforms
2
Training Material
1
Fact sheets
1
Countries / Regions
Global
8
India
7
Kenya
6
Western and Central Europe
6
South Africa
5
South–East Asia Region
4
Sierra Leone
3
Senegal
3
Zimbabwe
3
Nepal
3
Bangladesh
3
Ukraine
3
Venezuela
3
Eastern Europe
3
Nigeria
2
Ethiopia
2
Ghana
2
Uganda
2
Lebanon
2
Zambia
2
Syria
2
Tanzania
2
Rwanda
2
Malawi
2
Liberia
1
Congo, Democratic Republic of
1
Philippines
1
South Sudan
1
Iraq
1
Afghanistan
1
Thailand
1
Mozambique
1
Namibia
1
North Macedonia
1
Botswana
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Latin America and the Carribbean
1
Asia
1
Africa
1
Tajikistan
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Gabon
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
64
Clinical Guidelines
9
Public Health
8
Pharmacy & Technologies
7
Key Resources
6
Women & Child Health
1
Toolboxes
AMR
20
COVID-19
12
HIV
10
Mental Health
10
Pharmacy
8
TB
7
Conflict
5
NCDs
3
Malaria
3
Rapid Response
2
Caregiver
2
Planetary Health
2
NTDs
2
Specific Hazards
1
Global Health Education
1
Social Ethics
1
Health Financing Toolbox
1
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also re
...
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I
...
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market fo
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely
...
Strategic Overview
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3:
...
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping lab
...
10 years after the UN general assembly special session on drugs
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati
...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi
...
